Tecogen Inc.
Tecogen Inc. (TGEN) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Tecogen Inc. (TGEN), covering cash flow, earnings, and balance sheets.
Tecogen Inc. (TGEN) Income Statement & Financial Overview
Analyze Tecogen Inc.’s TGEN earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.08M | $5.63M | $4.73M | $6.19M |
| Cost of Revenue | $3.34M | $3.15M | $2.65M | $3.61M |
| Gross Profit | $2.73M | $2.48M | $2.08M | $2.58M |
| Gross Profit Ratio | $0.45 | $0.44 | $0.44 | $0.42 |
| R&D Expenses | $226843.00 | $233809.00 | $246489.00 | $254695.00 |
| SG&A Expenses | $3.43M | $3.12M | $3.30M | $3.38M |
| Operating Expenses | $3.87M | $3.35M | $3.55M | $3.63M |
| Total Costs & Expenses | $7.21M | $6.50M | $6.20M | $7.24M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $42271.00 | $23003.00 | $17869.00 | $18670.00 |
| Depreciation & Amortization | $134039.00 | $138246.00 | $141361.00 | $235053.00 |
| EBITDA | -$1.003M | -$734681.00 | -$1.33M | -$906746.00 |
| EBITDA Ratio | -$0.17 | -$0.13 | -$0.28 | -$0.15 |
| Operating Income | -$1.14M | -$873223.00 | -$1.47M | -$1.06M |
| Operating Income Ratio | -$0.19 | -$0.16 | -$0.31 | -$0.17 |
| Other Income/Expenses (Net) | -$42271.00 | -$22707.00 | -$36472.00 | -$15668.00 |
| Income Before Tax | -$1.18M | -$895930.00 | -$1.51M | -$1.07M |
| Income Before Tax Ratio | -$0.19 | -$0.16 | -$0.32 | -$0.17 |
| Income Tax Expense | $465.00 | $0.00 | $37.00 | $22063.00 |
| Net Income | -$1.19M | -$895930.00 | -$1.54M | -$1.10M |
| Net Income Ratio | -$0.20 | -$0.16 | -$0.33 | -$0.18 |
| EPS | -$0.05 | -$0.04 | -$0.06 | -$0.04 |
| Diluted EPS | -$0.05 | -$0.04 | -$0.06 | -$0.04 |
| Weighted Avg Shares Outstanding | $24.89M | $24.85M | $24.85M | $24.85M |
| Weighted Avg Shares Outstanding (Diluted) | $24.89M | $24.85M | $24.85M | $24.85M |
Financial performance has remained strong, with revenue growing from $6.19M in Q1 2024 to $6.08M in Q4 2024. Gross profit continued to perform well, with margins at 45% in the latest quarter. Operating income reached -$1.14M in Q4 2024, holding a steady -19% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$1.003M. Net income dropped to -$1.19M, keeping EPS at -$0.05. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan